Why is "Bayh–Dole Act" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-15 17:47:44
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
Bayh–Dole_Act entered the ranking for the first time today at position #. This is its highest position ever recorded.
Trend History
This topic has appeared in the English Wikipedia rankings 1 time. It first appeared on 2026-03-15 and was most recently seen on 2026-03-15.
Wikipedia Overview
The Bayh–Dole Act or Patent and Trademark Law Amendments Act is U.S. legislation permitting ownership by contractors of inventions arising from federal government-funded research. Sponsored by Senators Birch Bayh of Indiana and Bob Dole of Kansas, the Act was adopted in 1980, is codified at 94 Stat. 3015, and in 35 U.S.C. §§ 200–212, and is implemented by 37 C.F.R. 401 for federal funding agreements with contractors and 37 C.F.R 404 for licensing of inventions owned by the federal government.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
Advocates Urge Lawmakers to Protect the Bayh-Dole Act and Restart Small Business Innovation Grant Programs - Association of American Universities (AAU)
-
Save Bayh–Dole’s $2 Trillion Impact on American Innovation - National Review
-
Universities, Patents, and the Future of U.S. Competitiveness - CSIS | Center for Strategic and International Studies
-
The Bayh-Dole Act and the Debate Over “Reasonable Price” March-In Rights - The Federalist Society
-
Bayh-Dole Regulations for Federally Funded Inventions - National Institute of Standards and Technology (.gov)
-
Word of the Month: The Bayh-Dole Act - PhRMA
-
Basics of the Bayh-Dole Act: FAQs - Wilson Sonsini
-
Bayh-Dole Patent Trends - CSET | Center for Security and Emerging Technology
-
The Bayh-Dole Act: Selected Issues in Patent Policy and the Commercialization of Technology - Every CRS Report
-
The Bayh-Dole Act’s Vital Importance to the U.S. Life-Sciences Innovation System | Reports & Briefings | Mar 4, 2019 - Information Technology and Innovation Foundation (ITIF)
-
Both Sides Agree: Undermining Bayh-Dole Will Have Tragic Consequences for Innovation - IPWatchdog.com
-
The Legacy of Bayh-Dole's Success on U.S. Global Competitiveness Today - CSIS | Center for Strategic and International Studies
-
Preserve the Bayh-Dole Act and University Technology Transfer - Association of American Universities (AAU)
-
Setting the record straight on the Bayh-Dole Act and March-in - PhRMA
-
2018 Bayh-Dole Updates - National Institute of Standards and Technology (.gov)
-
IP Explained: Four things to know about the Bayh-Dole Act - PhRMA
-
A Database Rebuild to Champion the Bayh-Dole Act - National Institute of Standards and Technology (.gov)
-
The Bayh-Dole Act: Spurring American Biopharmaceutical Innovation - PhRMA
-
NIST Releases for Public Comment Draft Guidance on March-In Rights - National Institute of Standards and Technology (.gov)
-
IP Explained: FACT CHECK: March-In Authority and the Bayh-Dole Act - PhRMA
-
Penn is pushing back on a new federal rule that promises to lower drug costs - WHYY
-
The importance of the Bayh-Dole Act - PhRMA
-
Biden voted for the Bayh-Dole Act 44 years ago–but the administration's plans to reinterpret it could undermine decades of world-leading U.S. innovation - Fortune
-
Bayh-Dole Coalition Honors Researchers and Entrepreneurs with Faces of American Innovation Award - Association of American Universities (AAU)
-
Biden Executive Order Has Potential to Discourage U.S. Company Participation in Federal Research - Morrison Foerster
-
Federal Circuit Hints at the Scope of Government’s License Rights - Crowell & Moring LLP
-
What they are saying: Experts agree that proposed march-in framework would jeopardize innovation - PhRMA
-
Did You Know?: Purdue and the Bayh-Dole Act - Purdue University
-
Dole, Bayh bipartisan collaboration 40 years ago unlocks commercial potential of federal research - Kansas Reflector
-
Commerce Moves to Take Cut of Research Patents - AIP.ORG
-
Government Contracts Insights - Morrison Foerster
-
Buchanan Leads Letter Warning New Admin Proposal Could Stifle American Innovation - Congressman Vern Buchanan (.gov)
-
The Great American Science Heist - The Intercept
-
The Bayh-Dole Act - Morrison Foerster
-
Foundational mRNA patents are subject to the Bayh-Dole Act provisions - Knowledge Ecology International
-
Keeping Your Federally-Funded Inventions: Requirements to Comply with the Bayh-Dole Act - JD Supra
-
Several march-in and royalty free rights cases, under the Bayh-Dole Act - Knowledge Ecology International
-
President Biden: Don’t misuse Bayh-Dole march-in rights - statnews.com
-
Plan to lower drug costs may actually hurt U.S. legacy of innovation | Op-Ed - The Seattle Times
-
Trump Administration To Investigate Harvard’s Patents - The Harvard Crimson
-
Op-ed: Indiana's research pipeline is working. Don't cut it off, Purdue prof says - Journal & Courier
-
Biden’s march-in rights plan threatens future innovation | STAT - statnews.com
-
Whether and How the U.S. Government Should Exercise Its Compulsory Licensing Authority Under 28 U.S.C. § 1498 and the Bayh-Dole Act - NYU Journal of Intellectual Property & Entertainment Law
-
Bayh-Dole: The Innovation Engine that Congress Must Continue to Promote and Protect - Small Business & Entrepreneurship Council
-
DOE’s Misuse of Bayh-Dole’s ‘Exceptional Circumstances’ Provision: How Uniform Patent Policies Slip Away - IPWatchdog.com
-
Trump’s Attack on Harvard’s Patents Hits at Decades-Old IP Model - Bloomberg Law News
-
Our bipartisan bid to spur medical research still bearing fruit after 35 years - statnews.com
-
This law made ORNL a commercial powerhouse. A federal agency could jeopardize it - Knoxville News Sentinel
-
The Threat to University Patents (opinion) - Inside Higher Ed
-
IP expert Ruth Okediji discusses Biden administration’s ‘march-in’ proposal to target high drug prices - Harvard Law School
-
Why Is Sen. Bernie Sanders Holding Medical Innovation Hostage? - U.S. Chamber of Commerce
-
HE leaders oppose plan to tax licensed patent royalties - University World News
-
How Do Patent Incentives Affect University Researchers? - Stanford Law School
-
Biden Administration Proposes New Framework for Exercising March-In Rights on Government-Funded Inventions; Drug Pricing May Be Considered - JD Supra
-
DOE Imposes Strict Domestic Manufacturing Requirements on R&D Funding Recipients - AIP.ORG
-
Universities: Fallen Angels or Stewards of Bayh-Dole? - IPWatchdog.com
-
Patents and the Common Good - The New Atlantis
-
What academic research could learn from college athletics - statnews.com
-
The March-in Rights section of Xavier Becerra’s report on high drug prices - Knowledge Ecology International
-
Opinion | To succeed, Northern Metropolis should learn from Silicon Valley model - South China Morning Post
-
New Biden admin proposal legitimizes foreign IP theft - Post and Courier
-
A rare deterrent to limitless drug price increases may die under Trump - The Washington Post
-
In Memory: Farewell to Senator Birch Bayh - IPWatchdog.com
-
Opinion: The little-known law that gave birth to Google - SiliconValley.com
-
Opinion | Our Law Helps Patients Get New Drugs Sooner - The Washington Post
-
The Government Already Has The Tools It Needs To Make Pharmaceutical Drugs Affordable - If It Really Wanted To - Above the Law
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.